TL;DR
Medicaid may cover Ozempic for type 2 diabetes. It may deny Ozempic when prescribed only for weight loss because Ozempic is not FDA-approved for that use. Coverage depends on the diagnosis, state policy, managed-care plan, formulary, and prior authorization records.
Does Medicaid cover Ozempic? The short answer

Medicaid may cover Ozempic for type 2 diabetes. It may deny the same drug when prescribed only for weight loss. Ozempic is not FDA-approved for weight loss.
A prescription does not create coverage. The diagnosis, state rules, plan formulary, and prior authorization criteria control the claim.
Last reviewed: September 2026. Formularies can change before this page is updated. We recommend confirming the rule for the exact plan and fill date.
Ozempic for type 2 diabetes
A Medicaid plan may require a confirmed type 2 diabetes diagnosis. It may also request chart notes, A1C results, current medicines, prior treatments, and the requested dose.
Other restrictions may apply:
- Prior authorization
- Step therapy
- Preferred-drug rules
- Quantity limits
- Refill timing limits
- Authorization renewal dates
For example, a claim may reject even when the patient has diabetes and an A1C record. The prescriber may need to submit the diagnosis, lab results, metformin history, and dose request.
Ozempic for weight loss
Prescribing Ozempic only for weight loss is off-label. A Medicaid plan may exclude that use even when it covers Ozempic for diabetes.
Check weight-management drugs separately. Do not assume that Ozempic coverage proves coverage for Wegovy or another GLP-1 drug. Patients reviewing treatment progress can also use our four-week semaglutide weight-loss audit before discussing dose, adherence, or treatment changes with a prescriber.
Medicaid GLP-1 coverage by state and plan
Simple state labels can mislead. Each claim may pass through four layers: state policy, the fee-for-service drug list, a managed-care formulary, and patient-specific authorization rules.
The table below is a verification index for all 50 states and Washington, DC. “Unconfirmed” means the source material did not provide a current primary formulary rule. Use the official Medicaid state contact directory to find the current state source.
| State | Drug and indication | PA status | Fee-for-service rule | Managed-care variation | Primary source status | Last checked |
|---|---|---|---|---|---|---|
| Alabama | Ozempic—T2D; weight drugs separate | Unconfirmed | Check current PDL | Plan-specific | State confirmation needed | Sep. 2026 |
| Alaska | Ozempic—T2D; weight drugs separate | Unconfirmed | Check current PDL | Plan-specific if applicable | State confirmation needed | Sep. 2026 |
| Arizona | Ozempic—T2D; weight drugs separate | Unconfirmed | Check current PDL | Plan-specific | State confirmation needed | Sep. 2026 |
| Arkansas | Ozempic—T2D; weight drugs separate | Unconfirmed | Check current PDL | Plan-specific | State confirmation needed | Sep. 2026 |
| California | Ozempic—T2D; weight drugs separate | Unconfirmed | Check current drug list | Plan and benefit-specific | State confirmation needed | Sep. 2026 |
| Colorado | Ozempic—T2D; weight drugs separate | Unconfirmed | Check current PDL | Plan-specific | State confirmation needed | Sep. 2026 |
| Connecticut | Ozempic—T2D; weight drugs separate | Unconfirmed | Check current PDL | Program-specific | State confirmation needed | Sep. 2026 |
| Delaware | Ozempic—T2D; weight drugs separate | Unconfirmed | Check current PDL | Plan-specific | State confirmation needed | Sep. 2026 |
| District of Columbia | Ozempic—T2D; weight drugs separate | Unconfirmed | Check current PDL | Plan-specific | District confirmation needed | Sep. 2026 |
| Florida | Ozempic—T2D; weight drugs separate | Unconfirmed | Check current PDL | Plan-specific | State confirmation needed | Sep. 2026 |
| Georgia | Ozempic—T2D; weight drugs separate | Unconfirmed | Check current PDL | Plan-specific | State confirmation needed | Sep. 2026 |
| Hawaii | Ozempic—T2D; weight drugs separate | Unconfirmed | Check current PDL | Plan-specific | State confirmation needed | Sep. 2026 |
| Idaho | Ozempic—T2D reported covered; Wegovy weight loss reported excluded | Check criteria | Current PDL controls | Plan-specific | Primary rule not independently confirmed | Sep. 2026 |
| Illinois | Ozempic—T2D; weight drugs separate | Unconfirmed | Check current PDL | Plan-specific | State confirmation needed | Sep. 2026 |
| Indiana | Ozempic—T2D; weight drugs separate | Unconfirmed | Check current PDL | Plan-specific | State confirmation needed | Sep. 2026 |
| Iowa | Ozempic—T2D; weight drugs separate | Unconfirmed | Check current PDL | Plan-specific | State confirmation needed | Sep. 2026 |
| Kansas | Ozempic—T2D; weight drugs separate | Unconfirmed | Check current PDL | Plan-specific | State confirmation needed | Sep. 2026 |
| Kentucky | Ozempic—T2D; weight drugs separate | Unconfirmed | Check current PDL | Plan-specific | State confirmation needed | Sep. 2026 |
| Louisiana | Ozempic—T2D; weight drugs separate | Unconfirmed | Check current PDL | Plan-specific | State confirmation needed | Sep. 2026 |
| Maine | Ozempic—T2D; weight drugs separate | Unconfirmed | Check current PDL | Program-specific | State confirmation needed | Sep. 2026 |
| Maryland | Ozempic—T2D; weight drugs separate | Unconfirmed | Check current PDL | Plan-specific | State confirmation needed | Sep. 2026 |
| Massachusetts | Ozempic—T2D; weight drugs separate | Unconfirmed | Check current drug list | Plan-specific | State confirmation needed | Sep. 2026 |
| Michigan | Ozempic—T2D; weight drugs separate | Unconfirmed | Check current PDL | Plan-specific | State confirmation needed | Sep. 2026 |
| Minnesota | Ozempic—T2D; weight drugs separate | Unconfirmed | Check current PDL | Plan-specific | State confirmation needed | Sep. 2026 |
| Mississippi | Ozempic—T2D reported covered; Wegovy reported limited | Required for some uses | Current PDL controls | Plan-specific | Primary rule not independently confirmed | Sep. 2026 |
| Missouri | Ozempic—T2D; weight drugs separate | Unconfirmed | Check current PDL | Plan-specific | State confirmation needed | Sep. 2026 |
| Montana | Ozempic—T2D; weight drugs separate | Unconfirmed | Check current PDL | Plan-specific if applicable | State confirmation needed | Sep. 2026 |
| Nebraska | Ozempic—T2D; weight drugs separate | Unconfirmed | Check current PDL | Plan-specific | State confirmation needed | Sep. 2026 |
| Nevada | Ozempic—T2D; weight drugs separate | Unconfirmed | Check current PDL | Plan-specific | State confirmation needed | Sep. 2026 |
| New Hampshire | Ozempic—T2D; weight drugs separate | Unconfirmed | Check current PDL | Plan-specific | State confirmation needed | Sep. 2026 |
| New Jersey | Ozempic—T2D; weight drugs separate | Unconfirmed | Check current PDL | Plan-specific | State confirmation needed | Sep. 2026 |
| New Mexico | Ozempic—T2D; weight drugs separate | Unconfirmed | Check current PDL | Plan-specific | State confirmation needed | Sep. 2026 |
| New York | Ozempic—T2D; weight drugs separate | Unconfirmed | Check current drug list | Benefit and plan-specific | State confirmation needed | Sep. 2026 |
| North Carolina | Ozempic—T2D; weight drugs separate | Unconfirmed | Check current PDL | Plan-specific | State confirmation needed | Sep. 2026 |
| North Dakota | Ozempic—T2D; weight drugs separate | Unconfirmed | Check current PDL | Plan-specific if applicable | State confirmation needed | Sep. 2026 |
| Ohio | Ozempic—T2D; weight drugs separate | Unconfirmed | Check current PDL | Plan-specific | State confirmation needed | Sep. 2026 |
| Oklahoma | Ozempic—T2D; weight drugs separate | Unconfirmed | Check current PDL | Plan-specific | State confirmation needed | Sep. 2026 |
| Oregon | Ozempic—T2D; weight drugs separate | Unconfirmed | Check current drug list | Coordinated-plan rules vary | State confirmation needed | Sep. 2026 |
| Pennsylvania | Ozempic—T2D; weight drugs separate | Unconfirmed | Check current PDL | Plan-specific | State confirmation needed | Sep. 2026 |
| Rhode Island | Ozempic—T2D; weight drugs separate | Unconfirmed | Check current PDL | Plan-specific | State confirmation needed | Sep. 2026 |
| South Carolina | Ozempic—T2D; weight drugs separate | Unconfirmed | Check current PDL | Plan-specific | State confirmation needed | Sep. 2026 |
| South Dakota | Ozempic—T2D; weight drugs separate | Unconfirmed | Check current PDL | Plan-specific if applicable | State confirmation needed | Sep. 2026 |
| Tennessee | Ozempic—T2D; weight drugs separate | Unconfirmed | Check current PDL | Plan-specific | State confirmation needed | Sep. 2026 |
| Texas | Ozempic—T2D; weight drugs separate | Unconfirmed | Check current PDL | Plan-specific | State confirmation needed | Sep. 2026 |
| Utah | Ozempic—T2D; weight drugs separate | Unconfirmed | Check current PDL | Plan-specific | State confirmation needed | Sep. 2026 |
| Vermont | Ozempic—T2D; weight drugs separate | Unconfirmed | Check current PDL | Program-specific | State confirmation needed | Sep. 2026 |
| Virginia | Ozempic—T2D; weight drugs separate | Unconfirmed | Check current PDL | Plan-specific | State confirmation needed | Sep. 2026 |
| Washington | Ozempic—T2D; weight drugs separate | Unconfirmed | Check current drug list | Plan-specific | State confirmation needed | Sep. 2026 |
| West Virginia | Ozempic—T2D; weight drugs separate | Unconfirmed | Check current PDL | Plan-specific | State confirmation needed | Sep. 2026 |
| Wisconsin | Ozempic—T2D; weight drugs separate | Unconfirmed | Check current PDL | Program-specific | State confirmation needed | Sep. 2026 |
| Wyoming | Ozempic—T2D; weight drugs separate | Unconfirmed | Check current PDL | Plan-specific if applicable | State confirmation needed | Sep. 2026 |
The source material reports diabetes coverage for Ozempic in Idaho and Mississippi. It reports different Wegovy weight-management rules in those states. That difference shows why one GLP-1 cannot stand in for another.
Every row should be checked against primary sources at least once every 90 days. A dated table remains a starting point, not a payment promise.
How to read the state coverage table
- Covered: The formulary lists the drug for a covered use.
- Prior authorization required: The plan must approve the request before payment.
- Nonpreferred: The plan may require a preferred drug first.
- Excluded: The benefit does not cover the drug or stated use.
- Plan-specific: The member’s managed-care plan applies its own formulary or criteria within Medicaid rules.
The current member plan controls the pharmacy claim. Confirm the exact drug, strength, diagnosis, and fill date.
Why state policy may not match your plan
Managed-care organizations may use their own formularies. A state preferred drug list can include Ozempic while a managed-care plan treats it as nonpreferred.
Use the name on the current member ID card. Call the listed pharmacy benefit number, not an old state contact.
Fee-for-service Medicaid vs. Medicaid managed care

Fee-for-service Medicaid pays providers and pharmacies through the state program. Its state drug list and prior authorization rules usually control.
Medicaid managed care places the member in a health plan. That plan may maintain a separate formulary and use a pharmacy benefit manager to process claims.
The pharmacy benefit manager can explain claim processing and rejection codes. It is not always the final authority for an appeal. The plan handbook and denial notice state where an appeal must go.
Which formulary should you check?
Start with the plan name on the current Medicaid card. Then:
- Check the state preferred drug list.
- Check the managed-care formulary.
- Confirm the publication or effective date.
- Search for “Ozempic,” not only “semaglutide.”
- Confirm the prescribed strength and quantity.
The member portal, state Medicaid pharmacy page, plan formulary, and member handbook should provide these records.
What to do when two coverage sources conflict
Ask the plan which formulary applies on the planned fill date. Request the rule in writing or save the dated formulary page.
Then ask the pharmacy to submit the claim. Record the rejection code and full message. A claim result often identifies the next step more clearly than a general phone answer.
What Medicaid may require before it covers Ozempic
Prior authorization requires the prescriber to show that the request meets plan rules. Step therapy requires a patient to try a preferred treatment first unless an exception applies.
Plans may also impose preferred-drug rules, quantity limits, refill dates, and renewal deadlines. Criteria vary by state, plan, diagnosis, and date.
Diabetes requests may use A1C results, diagnosis records, and diabetes treatment history. Weight-management drug requests may use different records, such as BMI and weight-related conditions. Do not stop or change treatment without the prescriber.
Prior authorization records checklist
A complete request may include:
- Diagnosis and matching diagnosis code
- Recent chart notes
- Relevant lab results, including A1C when requested
- Current medicines
- Past treatment dates and outcomes
- Adverse effects
- Contraindications or reasons a preferred drug is unsuitable
- Requested dose and quantity
- Treatment and monitoring plan
“Insufficient clinical information” often means the plan needs more records. The prescriber can resubmit the missing material within the stated deadline.
Step therapy, quantity limits, and renewals
A plan may require a preferred diabetes drug before Ozempic. A prescriber can request an exception when the preferred option is not appropriate, but the plan will usually require a clinical reason.
Dose changes can also cause quantity rejections. Check the authorization end date before the next refill. An approval from six months ago may no longer support the current claim.
How to verify Ozempic coverage before the pharmacy fills it
Use one ordered process:
- Search the member portal or current formulary.
- Call the plan’s pharmacy benefit line.
- Give the prescriber the required authorization criteria.
- Ask the pharmacy to submit a claim before pickup.
- Record the date, representative, reference number, and exact response.
A verbal answer is not a guarantee of payment. The submitted pharmacy claim determines whether the fill processes under the current information.
Questions to ask the Medicaid plan
Ask these questions in order:
- Is Ozempic covered for my diagnosis?
- Does it require prior authorization?
- Does step therapy apply?
- Which clinical records are required?
- Is another GLP-1 preferred for this diagnosis?
- What quantity and refill limits apply?
- When would the authorization expire?
What to ask the prescriber and pharmacy
Ask the prescriber whether the authorization included chart notes, labs, diagnosis codes, and treatment history. Confirm when and where it was sent.
Ask the pharmacy for the exact rejection code and message. Confirm the current plan ID, prescribed dose, quantity, National Drug Code, authorization number, and refill date.
What to do if Medicaid denies Ozempic
Get the written denial. Record the appeal deadline.
Next, identify the denial type:
- Claim error: The pharmacy billed the wrong plan, quantity, code, or fill date.
- Missing information: The authorization lacks required records.
- Medical-necessity denial: The plan found that its clinical criteria were not met.
- Nonpreferred drug: The plan requires another treatment first.
- Benefit exclusion: The plan does not cover the drug for the requested use.
Do not move straight to cash payment. Check corrections, appeals, and covered alternatives first.
Fix a missing record or pharmacy claim error
Match the rejection to the action. A missing authorization number requires a different response than a refill-too-soon message.
The prescriber can resend chart notes or correct the request. After approval or correction, the pharmacy should rerun the claim using the current plan information.
Request an appeal or state fair hearing
Follow the instructions on the denial notice. Deadlines and appeal steps differ by state and plan.
An appeal may include:
- The denial notice
- The prescription
- Chart notes
- Lab records
- Treatment history
- Prior drug outcomes
- A prescriber statement
Some programs require a plan appeal before a state fair hearing. Use the sequence shown in the notice rather than relying on a national deadline.
Ask about a covered alternative
Request the preferred-drug list for the same covered diagnosis. Ask the prescriber whether a listed alternative fits the patient’s health needs.
Ozempic, Wegovy, Mounjaro, and Zepbound are not interchangeable for coverage purposes. Each has its own approved uses, doses, and plan criteria.
Does Medicaid cover Wegovy or other weight-loss drugs?
Medicaid weight-loss medication coverage varies by drug, state, plan, and diagnosis. A program may cover diabetes GLP-1 drugs while excluding drugs for chronic weight management.
Some formularies also list non-GLP-1 weight-loss drugs. Verify the exact drug name. Do not ask only whether the plan “covers weight-loss medicine.”
Ozempic vs. Wegovy
Ozempic and Wegovy both contain semaglutide. They have different approved uses, doses, and coverage rules.
Ozempic coverage does not prove Wegovy coverage. A patient denied Ozempic for weight loss can ask whether the plan separately covers Wegovy for chronic weight management.
Mounjaro vs. Zepbound
Mounjaro and Zepbound both contain tirzepatide. They also have different approved uses and plan criteria.
Coverage for Mounjaro does not transfer to Zepbound. The prescription, diagnosis, and authorization must match the requested brand.
When cash-pay care may be an option
Consider cash payment after correcting claim errors, using appeal rights, and reviewing covered alternatives. Cash payment is not Medicaid coverage. It may not count toward plan limits or other benefit calculations.
Temi keeps prescription and GLP-1 care in one place for patients considering an online cash-pay option. Clinical review is still required. We do not promise a prescription, insurance coverage, or a specific result.
FAQ
Can Medicaid cover Ozempic without type 2 diabetes?
It may, but coverage is less likely when Ozempic is prescribed only for weight loss. Ozempic is not FDA-approved as a weight-loss drug, and some plans exclude that use. Check the state and plan table, then ask whether an FDA-approved chronic weight-management drug has separate coverage.
How do I get Ozempic while on Medicaid?
First confirm that Ozempic is covered for the diagnosed condition. Complete any prior authorization and step therapy. Give the prescriber the plan’s records list, then ask the pharmacy to run the claim before pickup. Follow the coverage verification process and save all reference numbers.
How many months does it take to lose 20 pounds on Ozempic?
There is no fixed timeline. Ozempic is not approved as a weight-loss drug, and results vary by dose, diagnosis, starting weight, side effects, adherence, diet, and activity. A prescriber should set realistic review points and decide whether the treatment remains safe and appropriate rather than promising a set monthly loss.
What organ is Ozempic hard on?
No single organ is affected the same way in every patient. Ozempic’s prescribing information contains serious warnings and precautions that require clinical review. Discuss personal risks, health conditions, and other medicines with a prescriber. Seek prompt medical care for severe, persistent, or rapidly worsening symptoms.
Why did Medicaid reject my Ozempic refill?
Common causes include a refill-too-soon rule, quantity limit, expired authorization, dose change, or new health plan. The pharmacy may also have billed the wrong plan information. Ask for the exact rejection code before acting. If needed, use the denial steps to correct or appeal the decision.
Review your GLP-1 care options
Confirm the diagnosis, formulary, prior authorization rule, and claim result first. If Medicaid still will not cover the prescribed treatment, review cash-pay care with Temi and discuss the available options with a licensed prescriber.



